EUVIMEDEUVIMED entdecken
Open Access

A cuproptosis-based prognostic model for predicting survival in low-grade glioma

Zongren Zhao, Yuanhao Ma, Yu Liu, Zhongjun Chen, Jinyu Zheng

Aging · 2024

DOI: 10.18632/aging.205834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Zongren Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Affiliated Huaian Hospital of Xuzhou Medical University, Huaian 223002, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsHumansPrognosisNomogramsNeoplasm GradingTumor MicroenvironmentFemaleMaleGene Expression Regulation, NeoplasticBiomarkers, Tumor

Stichwörter der Autor:innen

LGGcuproptosisimmunological microenvironmentprognostic

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Affiliated Huaian Hospital of Xuzhou Medical University, Huaian 223002, China.
  • Department of Neurosurgery, Huzhou Central Hospital, Huzhou 313000, China.
  • Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou 221002, China.

Zitieren

APA

Zhao, Z., Ma, Y., Liu, Y., Chen, Z., & Zheng, J. (2024). A cuproptosis-based prognostic model for predicting survival in low-grade glioma. Aging. https://doi.org/10.18632/aging.205834

Vancouver

Zhao Z, Ma Y, Liu Y, Chen Z, Zheng J. A cuproptosis-based prognostic model for predicting survival in low-grade glioma. Aging. 2024. doi:10.18632/aging.205834

BibTeX
@article{Zhao2024,
  author = {Zhao, Zongren and Ma, Yuanhao and Liu, Yu and Chen, Zhongjun and Zheng, Jinyu},
  title = {A cuproptosis-based prognostic model for predicting survival in low-grade glioma},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205834}
}
Kostenlos starten →